Apollo launches ColFit screening programme to detect colorectal cancers
The initiative aims to improve survival rates, reduce treatment costs, and address the trend of late-stage diagnoses
Hyderabad: Apollo Cancer Centre (ACC), Hyderabad, on Wednesday announced the launch of ‘ColFit’, a comprehensive screening programme designed to detect and prevent colorectal cancer at an early stage.
The initiative aims to improve survival rates, reduce treatment costs, and address the trend of late-stage diagnoses, leading to poor outcomes and higher healthcare burdens, a press release said.
The ColFit programme will offer faecal immunochemical test (FIT), a non-invasive but regarded as an accurate screening tool to identify hidden blood in stool, a potential early indicator of CRC.
Dr Ajesh Raj Saksena, GI Surgical Oncologist, Apollo Cancer Centre; Dr Raghu DK, medical gastroenterologist, Apollo Hospitals; V Tejesvi, CEO – Telanagana Region, Apollo Hospitals; and other senior doctors were present during the launch of ColFit.
